--- a
+++ b/clusters/9knumclustersv2/clust_1209.txt
@@ -0,0 +1,40 @@
+Patients in their reproductive age group should use an effective method of birth control; patients who are breast-feeding, or have a positive pregnancy test will be excluded from the study
+Patients who are breastfeeding, pregnant or refuse to use an effective form of birth control are excluded; abstinence is considered an effective form of birth control
+Subjects of reproductive potential who are not willing to employ effective birth control from screening to  year after last dose of vaccine
+Subjects who are pregnant, breast feeding or sexually active and unwilling to use effective birth control while on treatment with TKI
+Patients who are pregnant, breast-feeding, or unwilling to practice an effective method of birth control
+Women of childbearing potential (WOCBP) who are pregnant or lactating or unwilling to use  forms of effective birth control
+Women who are breast feeding, or have a positive pregnancy test (reproductive age should use effective birth control during study if randomized to SBRT treatment arm)
+Effective birth control should be utilized as indicated
+Patients who are pregnant, breast feeding, or if sexually active and unwilling to use effective birth control for the duration of this study will be excluded
+Subjects in their reproductive age group should use an effective method of birth control; subjects who are breast-feeding, or have a positive pregnancy test will be excluded from the study
+Female patients who are pregnant or breast feeding, or adults who are of reproductive potential and are unwilling to refrain from conceiving a child during study treatment
+Pregnant, breastfeeding, or unwilling to practice birth control during participation in the study
+Pregnant and/or lactating women will be excluded; premenopausal patients will undergo pregnancy testing when indicated; women will practice effective birth control while receiving protocol treatment
+Any women who are pregnant or breast feeding, or women/men able to conceive and unwilling to practice an effective method of birth control
+Pregnancy or nursing or unwilling to take adequate birth control during therapy; NOTE: breastfeeding should be discontinued
+Patients must not be pregnant, lactating, or unwilling to use birth control
+Pregnant and lactating women are excluded from this study; women of reproductive potential that are not using or are unwilling to use effective birth control methods throughout the trial are excluded
+Patients that are pregnant, breast feeding, or unwilling to use effective contraception during the study
+Female subject who is pregnant, breastfeeding, or if of child bearing potential is unwilling to practice birth control until  years following surgery.
+Pregnancy or nursing or unwilling to take adequate birth control during therapy
+Women who are pregnant or breast feeding. Adults of reproductive potential not employing two forms of birth control as per Pregnancy Prevention Risk Management Plan.
+Patients who are breastfeeding, pregnant or refuse to use an effective form of birth control are excluded; abstinence is considered an effective form of birth control
+Participants must use effective birth control throughout study until at least  days after study treatment or  year after rituximab treatment, whichever is later; female participants must not be pregnant or breast-feeding
+Women who are pregnant or breast-feeding and women or men not practicing effective birth control
+Female patients who are pregnant or breast feeding, or adults of reproductive potential who are not using barrier birth control methods, are not eligible for participation
+Females who are pregnant or breast-feeding during the study period will be excluded; adults of reproductive potential not employing an effective method of birth control will be excluded; sexually active women of child bearing potential, whose partner is male, must use medically accepted birth control; sexually active men, whose partner is a female of childbearing potential, must use a medically accepted birth control
+Pregnant or breast feeding women, or women of child-bearing potential (and/or their partners) who are unwilling to utilize an approved method of birth control during the study and for  month afterward
+Women who are pregnant or breast-feeding and women or men not practicing effective birth control
+Females who are pregnant or need to breast feed during the study period will be excluded; patients found to be pregnant will be excluded; male and female enrolled patients will be advised to practice an effective method of birth control
+Subjects who are pregnant, breast feeding or sexually active and unwilling to use effective birth control for the duration of the study.
+The patient is pregnant or unwilling to practice appropriate birth control
+Not pregnant, not lactating, and agree to use effective birth control
+Pregnant or breastfeeding women and adults of reproductive potential not employing an effective method of birth control are excluded from this study
+Patients who are known or thought to be sexually active must use effective birth control.**
+If female patient with reproductive capacity: on effective means of barrier birth control during the entire duration of the treatment
+Pregnant women are ineligible, as treatment involves unforeseeable risks to the embryo or fetus; female patients with reproductive capacity are required to use effective means of birth control during the entire duration of the treatment
+Pregnant or able to become pregnant and unwilling to use two forms of birth control during the study period
+Pregnant, or had given birth, or nursed at any time during the last  months
+Women who are pregnant or breast feeding. Adults of reproductive potential not willing to employ two forms of birth control.
+Are pregnant, breastfeeding, or unwilling to practice an acceptable form of birth control during the study.